Early recognition and multidisciplinary management in this rare syndrome, especially in atypical oncological contexts, and early institution of immunosuppressive therapy are important steps in improving patients’ outcomes in paraneoplastic encephalitis are pointed out.
Abstract
Anti-Ma2 encephalitis is a rare paraneoplastic syndrome, mainly associated with germ cell tumors of the testis. This case report represents an atypical presentation of anti-Ma2 encephalitis in a 65-year- old female with lung adenocarcinoma. The patient presented with neuropsychiatric symptoms such as hallucinations and loss of recent memories and systemic symptoms of weight loss and night sweats. Evaluation showed bilateral hippocampal T2 hyperintensities on MRI and positivity for anti-Ma2 antibodies in serum. Initial treatment with corticosteroids resulted in partial symptomatic improvement; however, further relapses forced us to consider other immunotherapies such as rituximab and azathioprine. In spite of persistent memory deficits, the patient regained much of her general well-being. This case report points out early recognition and multidisciplinary management in this rare syndrome, especially in atypical oncological contexts. Careful malignancy workup and early institution of immunosuppressive therapy are important steps in improving patients’ outcomes in paraneoplastic encephalitis.
Immune checkpoint inhibitors such as pembrolizumab are increasingly used in cancer therapy and are associated with rare but serious immune-related neurological adverse effects, including autoimmune encephalitis.An 83-year-old woman with stage IV non-Hodgkin lymphoma presented with acute altered mental status---confusio...
Layal Ezzeddine, H. Abosheaishaa, Rajab Abdulsadek· ASIDE Oncology· 0 citations
Anti-leucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis is a rare neurological disorder caused by autoantibodies targeting the LGI1 protein, leading to synaptic dysfunction predominantly affecting the temporal lobes and hippocampi. It is mainly characterized by cognitive impairment, focal seizures, and fa...
L. Wolff, Mathieu Zuber, V. Roubeau· La Revue de medecine interne· 0 citations
During disease progression, innovative sequential therapy with efgartigimod, an FcRn antagonist, was followed by the anti-CD20 monoclonal antibody rituximab (RTX) to reduce the risk of profound B-cell depletion, thereby demonstrating synergistic efficacy.
Jun-Tong Liu, Wen-Ping Zhu, Lan Gao et al.· Frontiers in Immunology· 1 citation
Findings support the possibility that anti-mGluR1 encephalitis may, in rare instances, present with predominant brainstem involvement and testing for anti-mGluR1 antibodies may be considered in patients with otherwise unexplained subacute inflammatory brainstem syndromes.
Paraneoplastic cerebellar degeneration (PCD) is a rare autoimmune neurological syndrome associated with breast carcinoma and anti-Yo antibodies. Neurological symptoms often precede the diagnosis of the underlying malignancy. A 48-year-old woman presented with progressive swaying while walking for three months, slurred...
G. Harshini, Raghu Teja K.J.S.S.· Indian Journal of Case Repor...· 0 citations
BACKGROUND
Morvan Syndrome is an ultra rare autoimmune channelopathy characterized by neuromyotonia, autonomic instability, and central nervous system involvement. While typically associated with thymoma in adults, its manifestation in adolescents is exceptionally rare and poses significant diagnostic challenges.
CAS...
B. Aynekin, S. Efthymiou, H. Houlden et al.· Brain & development (Tokyo....· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.